U. Rosenschein et al., SAFETY OF CORONARY ULTRASOUND ANGIOPLASTY - EFFECTS OF SONICATION ON INTACT CANINE CORONARY-ARTERIES, Catheterization and cardiovascular diagnosis, 35(1), 1995, pp. 64-71
The purpose of this work was to examine in vivo the safety of sonicati
on in the coronary arteries in a live animal model. In intact dogs (n
= 8), balloon dilatation was performed on the proximal left anterior d
escending artery (LAD) followed by sonication to the left circumflex a
rtery (LCX) in power levels found to be optimal for thrombus ablation.
Post-dilatation and post-ultrasound coronary angiography, echocardiog
raphy, histopathology, CK-MB, indices of hemolysis, and coagulation we
re compared. Sonication did not induce changes in the ECG or blood pre
ssure. Coronary angiography revealed no adverse side effects or change
in arterial diameter (2.3 +/- 0.7 vs. 2.4 +/- 0.3 mm). Echocardiograp
hy showed transient opacification of the myocardium. Histopathology re
vealed a comparable minimal degree of endothelial denudation. After so
nication there were no changes in the level of CK-MB (312 +/- 168 vs.
283 +/- 207 IU), hemoglobin (11.3 +/- 0.9 vs. 12.7 +/- 1.1 gr%), hapto
globin (479 +/- 136 vs. 451 +/- 121 mg/dL), fibrinogen (142 +/- 18 vs,
165 +/- 28 mg%), partial thromboplastin time (17.3 +/- 3.2 vs. 17.6 /- 3.4 sec), prothrombin time (13.3 +/- 7.8 vs. 11.5 +/- 2.9 sec), and
degree of platelet aggregation (55 +/- 17 vs. 62 +/- 8%), Thus, the d
ata suggest that transluminal coronary sonication exerts no overt adve
rse effects invivo. (C) 1995 Wiley-Liss, Inc.